Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Temazepam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for temazepam and what is the scope of temazepam freedom to operate?

Temazepam
is the generic ingredient in three branded drugs marketed by Duramed Pharms Barr, Actavis Elizabeth, Mylan, Sandoz, Watson Labs, Quantum Pharmics, Novel Labs Inc, Mallinckrodt Inc, Sun Pharm Inds, Prinston Inc, Amneal Pharms, and Usl Pharma, and is included in twenty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for temazepam. Forty-one suppliers are listed for this compound.

Summary for Generic Name: temazepam

Tradenames:3
Patents:1
Applicants:12
NDAs:23
Drug Master File Entries: see list7
Suppliers / Packagers: see list41
Bulk Api Vendors: see list15
Patent Applications: see list5,590
Drug Prices:see low prices
DailyMed Link:temazepam at DailyMed

Pharmacology for Ingredient: temazepam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
TEMAZEPAM
temazepam
CAPSULE;ORAL071174-001Jul 10, 1986DISCNNoNo► Subscribe► Subscribe
Amneal Pharms
TEMAZEPAM
temazepam
CAPSULE;ORAL203482-003May 23, 2016ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds
TEMAZEPAM
temazepam
CAPSULE;ORAL071175-002Sep 14, 2009ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds
TEMAZEPAM
temazepam
CAPSULE;ORAL078581-001Sep 8, 2009ABRXNoNo► Subscribe► Subscribe
Mallinckrodt Inc
RESTORIL
temazepam
CAPSULE;ORAL018163-004Nov 2, 2004ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot